COVID-19 & CancerFreeNCI Sharpless: COVID-19 threatens to reverse long-running trend of decreasing cancer mortality May 15, 2020Vol.46 No.20By Matthew Bin Han Ong
COVID-19 & CancerFree With $306M for serology research, NCI mobilizes labs, academic centers, grantees, contractors, and SBIR May 15, 2020Vol.46 No.20By Paul Goldberg
Conversation with The Cancer LetterCOVID-19 & CancerFree Nancy Davidson describes plans for reopening the Seattle Cancer Care Alliance as COVID-19 wave recedes May 15, 2020Vol.46 No.20By Paul Goldberg
Conversation with The Cancer LetterCOVID-19 & CancerFree Lessons from COVID-19:Leaders of six cancer centers in the DMV area tell us about caseloads, the outlook—and impact May 08, 2020Vol.46 No.19By Matthew Bin Han Ong
COVID-19 & CancerFree COVID-19 slams into the nation’s capital region; Here is the damage assessment at six institutions May 08, 2020Vol.46 No.19By Matthew Bin Han Ong
COVID-19 & CancerFree NCI receives $306 million in new money for COVID-19 serology test research;Details to follow at BSA meeting May 12 May 08, 2020Vol.46 No.19By Paul Goldberg
COVID-19 & CancerFreeGuest Editorial With the COVID-19 pandemic, the cancer clinical trials—they are a-changing May 08, 2020Vol.46 No.19By Gregory Masters, Nicholas J. Petrelli and Kandie Dempsey
COVID-19 & CancerFreeGuest Editorial Embracing the increasing value of eHealth in patient-centered cancer care during the COVID-19 pandemic and beyond May 08, 2020Vol.46 No.19By Frank J. Penedo and Joshua Kronenfeld
FreeObituary Paul A. Marks, architect of modern academic oncology who led MSK for two decades, dies at 93 May 08, 2020Vol.46 No.19By Larry Norton
COVID-19 & CancerFree Fox Chase will not be sold to Jefferson after allDeal becomes a “casualty of COVID-19” May 08, 2020Vol.46 No.19By Paul Goldberg
